{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T04:09:15Z","timestamp":1744517355896,"version":"3.40.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Treatment satisfaction can be described as the patient\u2019s experience in patients with cystic fibrosis (CF). It can be influenced using modulators and clinical characteristics. The aims of this study were to evaluate and compare adult CF patients with and without modulators regarding treatment satisfaction, related factors and to manage their drug related problems (DRPs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A single-center prospective cohort study was conducted between June 2023 and January 2024. Treatment Satisfaction Questionnaire for Medication (TSQM 1.4), including effectiveness, side effects, convenience, global satisfaction domains, CF Questionnaire-Revised (CFQ-R), and Medication Adherence Report Scale were applied and assessed with and without modulator therapy groups. The relationship between clinical characteristics and TSQM was analyzed by correlations and regression analysis. Recommendations on DRPs identified by clinical pharmacists were made to the physicians and patients and classified according to Pharmaceutical Care Network Europe (PCNE v9.1).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 110 patients with 51 modulator therapy and 59 without modulator therapy were included. The mean global satisfaction score of modulator users was found to be 19.733 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) points higher than non-users. When the CFQ-R treatment burden score improved by 1point, global satisfaction score increased by 0.233 points (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). When the number of hospitalizations increased by 1\u00a0day, the global satisfaction score decreased by 4.751 points (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). A total of 84 DRPs were identified, and 69 (82.1%) of them were resolved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Treatment satisfaction in adult CF patients is influenced by modulators, treatment burden, and clinical factors, so access to modulators is important. This is the first study to classify DRPs according to PCNE in CF. Clinical pharmacists contribute to the management of CF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03676-6","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T20:44:15Z","timestamp":1744490655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Are adult cystic fibrosis patients satisfied with medication treatment?"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9630-8855","authenticated-orcid":false,"given":"Esen Deniz","family":"Akman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-8727","authenticated-orcid":false,"given":"Nadir","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6071-0851","authenticated-orcid":false,"given":"O\u011fuz","family":"Karc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-2100","authenticated-orcid":false,"given":"Ebru","family":"Damado\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-3775","authenticated-orcid":false,"given":"Ali Fuat","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-5826","authenticated-orcid":false,"given":"Kutay","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"1","key":"3676_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chest.2022.07.004","volume":"163","author":"P-R Burgel","year":"2023","unstructured":"Burgel P-R, Burnet E, Regard L, Martin C. The changing epidemiology of cystic fibrosis: the implications for adult care. Chest. 2023;163(1):89\u201399.","journal-title":"Chest"},{"issue":"11","key":"3676_CR2","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/antibiotics11111637","volume":"11","author":"RM Gir\u00f3n","year":"2022","unstructured":"Gir\u00f3n RM, Pel\u00e1ez A, Ib\u00e1\u00f1ez A, Mart\u00ednez-Besteiro E, G\u00f3mez-Punter RM, Mart\u00ednez-Vergara A, et al. Longitudinal study of therapeutic adherence in a cystic fibrosis unit: identifying potential factors associated with medication possession ratio. Antibiotics. 2022;11(11):1637.","journal-title":"Antibiotics"},{"issue":"2","key":"3676_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056247","volume":"8","author":"S Delestras","year":"2013","unstructured":"Delestras S, Roustit M, Bedouch P, Minoves M, Dobremez V, Mazet R, et al. Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases. PLoS ONE. 2013;8(2): e56247.","journal-title":"PLoS ONE"},{"issue":"1","key":"3676_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5114\/reum\/161575","volume":"61","author":"S Miladi","year":"2023","unstructured":"Miladi S, Belhadj W, Boussaa H, Yasmine M, Leith Z, Abdelghani KB, et al. Patient satisfaction with medication in rheumatoid arthritis: an unmet need. Reumatologia. 2023;61(1):38.","journal-title":"Reumatologia"},{"issue":"1","key":"3676_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41927-022-00251-5","volume":"6","author":"H Abu Hamdeh","year":"2022","unstructured":"Abu Hamdeh H, Al-Jabi SW, Koni A, Zyoud SEH. Health-related quality of life and treatment satisfaction in Palestinians with rheumatoid arthritis: a cross-sectional study. BMC Rheumatol. 2022;6(1):19.","journal-title":"BMC Rheumatol"},{"issue":"6","key":"3676_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jcf.2012.04.007","volume":"11","author":"A Regnault","year":"2012","unstructured":"Regnault A, Balp M-M, Kulich K, Viala-Danten M. Validation of the treatment satisfaction questionnaire for medication in patients with cystic fibrosis. J Cyst Fibros. 2012;11(6):494\u2013501.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"3676_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.japh.2018.01.006","volume":"58","author":"O Abraham","year":"2018","unstructured":"Abraham O, Li JS, Monangai KE, Feathers AM, Weiner D. The pharmacist\u2019s role in supporting people living with cystic fibrosis. J Am Pharm Assoc. 2018;58(3):246\u20139.","journal-title":"J Am Pharm Assoc"},{"key":"3676_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-2-1","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:1\u201313.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"3676_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/ped.14553","volume":"63","author":"G Alishbayli","year":"2021","unstructured":"Alishbayli G, Kilinc AA, Cokugras H. Evaluation of the health-related quality of life in Turkish cystic fibrosis patients. Pediatr Int. 2021;63(8):965\u201370.","journal-title":"Pediatr Int"},{"key":"3676_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11136-012-0152-4","volume":"22","author":"H Yuksel","year":"2013","unstructured":"Yuksel H, Yilmaz O, Dogru D, Karadag B, Unal F, Quittner AL. Reliability and validity of the cystic fibrosis questionnaire-revised for children and parents in Turkey: cross-sectional study. Qual Life Res. 2013;22:409\u201314.","journal-title":"Qual Life Res"},{"issue":"1","key":"3676_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.26650\/IUITFD.413637","volume":"82","author":"T\u015e Esin","year":"2019","unstructured":"Esin T\u015e, Hanife SB, Dil\u015fad S. The validity and reliability study of the Turkish adaptation of medical adherence report scale. J Istanb Fac Med. 2019;82(1):52\u201361.","journal-title":"J Istanb Fac Med"},{"key":"3676_CR12","unstructured":"Up to Date Drug Interactions 2024 [Available from: https:\/\/www.uptodate.com\/contents\/search."},{"issue":"7","key":"3676_CR13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","volume":"187","author":"PJ Mogayzel Jr","year":"2013","unstructured":"Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3676_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","volume":"17","author":"C Castellani","year":"2018","unstructured":"Castellani C, Duff AJ, Bell SC, Heijerman HG, Munck A, Ratjen F, et al. ECFS best practice guidelines: the 2018 revision. J Cyst Fibros. 2018;17(2):153\u201378.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"3676_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","volume":"35","author":"D Turck","year":"2016","unstructured":"Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557\u201377.","journal-title":"Clin Nutr"},{"key":"3676_CR16","unstructured":"Europe PCN. The PCNE Classification V 9.1. Pharmaceutical Care Network Europe Foundation [Updated 1005 20, Accessed 0507 21][Available from: https:\/\/www.pcne.org\/upload\/files\/417_PCNE_classification_V9-1_final.pdf. 2020."},{"key":"3676_CR17","unstructured":"Alpar R. Uygulamal\u0131 \u0130statistik ve Ge\u00e7erlik-G\u00fcvenilirlik. Ankara: Detay Yay\u0131nc\u0131l\u0131k; 2022."},{"key":"3676_CR18","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.2147\/PPA.S102234","volume":"10","author":"J Greenberg","year":"2016","unstructured":"Greenberg J, Palmer JB, Chan WW, Correia CE, Whalley D, Shannon P, et al. Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder. Patient Prefer Adher. 2016;10:2163\u20139.","journal-title":"Patient Prefer Adher"},{"key":"3676_CR19","doi-asserted-by":"publisher","first-page":"1168249","DOI":"10.3389\/fpubh.2023.1168249","volume":"11","author":"J Wu","year":"2023","unstructured":"Wu J, Meng W, Zeng H, Ma Y, Chen Y. Satisfaction with medication in older adult patients with chronic respiratory diseases: a multicenter cross-sectional observational study. Front Public Health. 2023;11:1168249.","journal-title":"Front Public Health"},{"issue":"6","key":"3676_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1074248418784292","volume":"23","author":"S Jneid","year":"2018","unstructured":"Jneid S, Jabbour H, Hajj A, Sarkis A, Licha H, Hallit S, et al. Quality of life and its association with treatment satisfaction, adherence to medication, and trust in physician among patients with hypertension: a cross-sectional designed study. J Cardiovasc Pharmacol Ther. 2018;23(6):532\u201342.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"21","key":"3676_CR21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/jama.2023.8120","volume":"329","author":"T Ong","year":"2023","unstructured":"Ong T, Ramsey BW. Cystic fibrosis: a review. JAMA. 2023;329(21):1859\u201371.","journal-title":"JAMA"},{"key":"3676_CR22","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/ppul.25613","volume":"57","author":"JJ Grant","year":"2022","unstructured":"Grant JJ, McDade EJ, Zobell JT, Young DC. The indispensable role of pharmacy services and medication therapy management in cystic fibrosis. Pediatr Pulmonol. 2022;57:S17\u201339.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"3676_CR23","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.japh.2021.04.005","volume":"61","author":"N Warda","year":"2021","unstructured":"Warda N, Rotolo SM. Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit. J Am Pharm Assoc. 2021;61(5):e119\u201325.","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"3676_CR24","first-page":"306","volume":"27","author":"ES Yett","year":"2022","unstructured":"Yett ES, Phan H, Mills AR, Fleming JW, Majure JM, Malinowski SS, et al. Development and evaluation of a pharmacist-driven vitamin D protocol for a cystic fibrosis clinic. J Pediatr Pharmacol Ther. 2022;27(4):306\u201311.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"3676_CR25","unstructured":"Zolin A, Adamoli A, Bakkeheim E, van Rens J, et al. ECFSPR Annual Report 2022. 2024."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03676-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T20:44:18Z","timestamp":1744490658000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03676-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3676"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03676-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Hacettepe University. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}